BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20563710)

  • 1. Varicella zoster virus immune evasion strategies.
    Abendroth A; Kinchington PR; Slobedman B
    Curr Top Microbiol Immunol; 2010; 342():155-71. PubMed ID: 20563710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of the Innate Immune Response by Varicella Zoster Virus.
    Gerada C; Campbell TM; Kennedy JJ; McSharry BP; Steain M; Slobedman B; Abendroth A
    Front Immunol; 2020; 11():1. PubMed ID: 32038653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies.
    Hakami MA; Khan FR; Abdulaziz O; Alshaghdali K; Hazazi A; Aleissi AF; Abalkhail A; Alotaibi BS; Alhazmi AYM; Kukreti N; Binshaya AS
    Rev Med Virol; 2024 Jul; 34(4):e2554. PubMed ID: 38862398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VZV infection of keratinocytes: production of cell-free infectious virions in vivo.
    Gershon MD; Gershon AA
    Curr Top Microbiol Immunol; 2010; 342():173-88. PubMed ID: 20225011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of varicella-zoster virus on dendritic cell subsets in human skin during natural infection.
    Huch JH; Cunningham AL; Arvin AM; Nasr N; Santegoets SJ; Slobedman E; Slobedman B; Abendroth A
    J Virol; 2010 Apr; 84(8):4060-72. PubMed ID: 20130046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
    Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
    Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: The neurobiology of varicella zoster virus infection.
    Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
    Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
    J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Varicella-zoster virus (VZV)].
    Kanai K; Yamada S; Inoue N
    Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological evasion of immediate-early varicella zoster virus proteins.
    Meysman P; Fedorov D; Van Tendeloo V; Ogunjimi B; Laukens K
    Immunogenetics; 2016 Jul; 68(6-7):483-486. PubMed ID: 27020058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella-zoster virus immune evasion.
    Abendroth A; Arvin A
    Immunol Rev; 1999 Apr; 168():143-56. PubMed ID: 10399071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instruction.
    Gutzeit C; Raftery MJ; Peiser M; Tischer KB; Ulrich M; Eberhardt M; Stockfleth E; Giese T; Sauerbrei A; Morita CT; Schönrich G
    J Immunol; 2010 Jul; 185(1):488-97. PubMed ID: 20525895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.
    González-Motos V; Jürgens C; Ritter B; Kropp KA; Durán V; Larsen O; Binz A; Ouwendijk WJD; Lenac Rovis T; Jonjic S; Verjans GMGM; Sodeik B; Krey T; Bauerfeind R; Schulz TF; Kaufer BB; Kalinke U; Proudfoot AEI; Rosenkilde MM; Viejo-Borbolla A
    PLoS Pathog; 2017 May; 13(5):e1006346. PubMed ID: 28542541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
    Wittek AE; Arvin AM; Koropchak CM
    J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.